معرفی
Caroline Sophie Verbeke is a Professor at the University of Oslo's Department of Pathology, Faculty of Medicine. Her research focuses on pancreatic pathology, particularly in pancreatobiliary diseases and endocrine neoplasia. She leads studies on tumor response assessment in pancreatic cancer after neoadjuvant therapy and has contributed to international consensus guidelines in pancreatic pathology.
Her work spans translational research, including biomarker discovery for treatment response (e.g., metabolomics and proteomics), AI-driven imaging analysis, and clinical trials like NORPACT-1 and NORPACT-2. She has published extensively on pancreatic cancer staging, surgical outcomes, and histopathological evaluation challenges. Collaborations include international teams addressing tumor regression grading and AI-based segmentation.
Key contributions include advocating standardized pathology reporting for pancreatic cancer and exploring prognostic markers like tumor-stroma ratios. While no explicit awards are listed, her influence is evident through high-impact studies on pancreatic cancer management and treatment strategies.
